Optimi Health Corp

Psyence Biomedical Ltd. (NASDAQ:PBM), a biotechnology company focused on creating natural psychedelic-based solutions to address mental health challenges, has issued an update to shareholders, highlighting significant recent developments and upcoming milestones. The company has initiated a Phase...

Canadian licensed producer of GMP-grade psilocybin Optimi Health Corp. (OTCQX: OPTHF) closed a non-brokered private placement of 5,692,308 Optimi units at $0.236 each, for gross proceeds of $1.346.245 with Wilson Capital, the private equity division at Chip Wilson’s family office, and...

Optimi Health Corp (OTCQX: OPTHF) acquired thirty-three types of psilocybin and mushroom strains intended for cultivation. The company will hold a set of twenty-four psychedelic and nine functional strains, adding them to one of the largest genetic banks in the sector. The psychedelic strains will...